Annual accounts
Total Exemption Full accounts
30/09/2026Filing deadline
Made up to 31/12/2024Due 30/09/2026
- Next accounts made up to
- 31/12/2025
- Last accounts made up to
- 31/12/2024
OXFORD DRUG DESIGN LIMITED
Active- 04305857Copy
Copy
Registry details
Reference data exactly as held at Companies House.
Copy registry details
- Registered office
- Oxford Centre For Innovation Blue Boar Court, 9 Alfred Street, Oxford OX1 4EH
- Classification (SIC)
- Research and experimental development on biotechnology (72.11 - SIC 2007)
- Accounts type
- Total Exemption Full
Company activity
The 4 most recent documents filed at Companies House.
Pre-Score for UK companies is coming soon
- 04/09/2026View PDF (3 pages)
Statement of capital following an allotment of shares on 2026-07-17
- 26/07/2026View PDF (3 pages)
Statement of capital following an allotment of shares on 2026-06-05
- 24/07/2026View PDF (4 pages)
Replacement filing of SH01 - 24/03/26 Statement of Capital gbp 941686.06
- 13/04/2026View PDF (3 pages)
Statement of capital following an allotment of shares on 2025-12-19
Coming soon
What Pre-Score will tell you
- Whether the filed accounts are strengthening or weakening year on year.
- Whether this company files on time, and how often its record changes.
- How its officers and controlling parties connect to other UK companies.
Accounts and confirmation statement
The two filings Companies House requires every year, and where each one stands against its deadline today.
Due in 5 days
Confirmation statement
Confirms the registry record is up to date
- Next statement date
- 29/10/2026
- Last statement dated
- 31/12/2024
Financial performance
The latest figures OXFORD DRUG DESIGN LIMITED filed. Okredo holds filed accounts data for 2021–2025; the year-by-year record is on the financials page.
Net Assets
£438.86K2025
53.10%vs 20242024: £286.65K
Total Assets
£565.15K2025
1.92%vs 20242024: £554.52K
Cash in Bank
£432.12K2024
-20.49%vs 20232023: £543.46K
Total Liabilities
£126.29K2025
-52.36%vs 20242024: £265.11K
Employees
72025
0vs 20242024: 7
Of the 4 measures with an earlier filing to compare against, 2 rose and 2 fell. Net assets moved furthest, up 53.10% on 2024. See the full financial analysis for OXFORD DRUG DESIGN LIMITED.
The full financial record
Four ways through OXFORD DRUG DESIGN LIMITED's filed accounts — the year-by-year numbers, the compound rates and the ratios behind them.
Net Assets · -24.7% a year (CAGR)Three-year trend, 2023–2025Every measure end to end across 2023, 2024 and 2025, with the compound rate behind each one.See what moved5 chartsCharts by indicator5 filed indicators plotted year by year, 2021–2025.Plot the figuresNothing estimatedRatios from the filed figures4 ratios computed from this company's own reported amounts, each shown against the year it was derived from.Check the ratios5 × 5 yearsEvery figure by yearAll 5 measures Okredo tracks across 5 reported years, exactly as filed.Open the table
Employees
Headcount as reported to Companies House for 2021–2025.
| Year | Employees | Change |
|---|---|---|
| 2025 | 7 | 0 |
| 2024 | 7 | 0 |
| 2023 | 7 | -1 |
| 2022 | 8 | -1 |
| 2021 | 9 | – |
Reported employee count decreased from 9 in 2021 to 7 in 2025. See how headcount moved alongside the reported financials.
Credit report
It is a professional assessment of the company 's performance, revealing company's potential and risks, showing it's past experiences and revealing future prospects.
- Company potential
- Risk indicators
- Past performance
- Future prospects
Officers
27Directors, secretaries and other appointed officers, with the period each has served.
| Person | Role | Period | Connected companies |
|---|---|---|---|
| Corporate Director | 26/07/2022–17/04/2023 | 180 | |
| Corporate Director | 10/07/2012–30/06/2019 | 180 | |
| Corporate Secretary | 10/07/2012–05/02/2020 | 180 | |
| Director | 26/07/2022–26/07/2022 | 1 | |
| Corporate Secretary | 05/02/2020–31/05/2021 | 23 | |
| Director | 01/12/2005–07/06/2012 | 11 | |
| Corporate Secretary | 17/10/2001–01/12/2005 | 109 | |
| Corporate Director | 17/10/2001–18/11/2001 | 35 | |
| Director | 27/02/2003–Present | 3 | |
| Director | 16/11/2020–Present | 4 | |
| Director | 18/11/2001–22/06/2005 | 49 | |
| Director | 20/05/2019–03/10/2023 | 19 | |
| Director | 18/11/2001–12/02/2025 | 12 | |
| Director | 18/11/2001–28/10/2002 | 20 | |
| Director | 25/06/2009–07/06/2012 | 22 | |
| Director | 18/11/2001–17/07/2003 | 8 | |
| Director | 20/05/2019–Present | 4 | |
| Director | 22/06/2005–25/06/2009 | 7 | |
| Director | 24/03/2005–25/06/2009 | 9 | |
| Secretary | 01/12/2005–26/03/2008 | 1 | |
| Secretary | 26/03/2008–10/07/2012 | 1 | |
| Director | 30/04/2010–15/10/2012 | 1 | |
| Secretary | 17/04/2023–Present | 0 | |
| Director | 27/03/2017–Present | 0 | |
| Secretary | 31/05/2021–17/04/2023 | 0 | |
| Director | 27/03/2017–14/02/2018 | 0 | |
| Director | 17/09/2024–Present | 0 |
Persons with significant control
2Individuals or entities with significant control over the company, as declared to Companies House.
| Person | Period | Connected companies |
|---|---|---|
| 06/04/2016–20/05/2019 | 0 | |
| 20/05/2019–Present | 0 |
Filing history and recent activity
Every document on the Companies House record, newest first.
- Filings on record
- 29 Since 12/11/2022
- Last 12 months
- 9 -2 vs the year before
- Most recent filing
- 04/09/2026 less than a month ago
What changed in the last year
- Share capital (6)Latest 04/09/2026
- Confirmation statementLatest 03/11/2025
- Registered officeLatest 03/11/2025
Filing timeline
- 04/09/2026View PDF (3 pages)
Statement of capital following an allotment of shares on 2026-07-17
- 26/07/2026View PDF (3 pages)
Statement of capital following an allotment of shares on 2026-06-05
- 24/07/2026View PDF (4 pages)
Replacement filing of SH01 - 24/03/26 Statement of Capital gbp 941686.06
- 13/04/2026View PDF (3 pages)
Statement of capital following an allotment of shares on 2025-12-19
- 09/04/2026View PDF (4 pages)
Statement of capital following an allotment of shares on 2026-03-24
- 06/01/2026View PDF (3 pages)
Statement of capital following an allotment of shares on 2025-12-19
- 04/11/2025View PDF (1 pages)
Register inspection address has been changed from Oxford Centre for Innovation New Road Oxford OX1 1BY England to Oxford Centre for Innovation Blue Boar Court Alfred Street Oxford OX1 4EH
- 03/11/2025View PDF (9 pages)
Confirmation statement made on 2025-10-29 with updates
- 03/11/2025View PDF (1 pages)
Register(s) moved to registered office address Oxford Centre for Innovation Blue Boar Court 9 Alfred Street Oxford OX1 4EH
- 06/08/2025View PDF (13 pages)
Total exemption full accounts made up to 2024-12-31
- 20/06/2025View PDF (4 pages)
Second filing of a statement of capital following an allotment of shares on 2025-04-01
- 18/06/2025View PDF (4 pages)
Statement of capital following an allotment of shares on 2025-04-01
Showing 12 of 29 filings
See when the next accounts and confirmation statement are due
Similar companies
84 UK companies are similar to OXFORD DRUG DESIGN LIMITED, sharing the same company status (Active), the same industry sector and activity group (Research and experimental development on biotechnology) and a comparable number of employees. The 5 closest matches are shown below to help you compare competitors and industry peers.
ELIPTICA LIMITED
Active2 Communications Road, Greenham Business Park, Newbury, Berkshire RG19 6AB
- Activity
- Research and experimental development on biotechnology
- Company no.
- 14041502
- Incorporated
- 12/04/2022
- Employees
- 5
LAMBDA ENERGY LTD
ActiveAllia Future Business Centre, Kings Hedges Road, Cambridge CB4 2HY
- Activity
- Other research and experimental development on natural sciences and engineering
- Company no.
- 11246890
- Incorporated
- 10/03/2018
- Employees
- 5
AKL RESEARCH & DEVELOPMENT LIMITED
ActiveThe Lexicon Second Floor, Mount Street, Manchester M2 5NT
- Activity
- Research and experimental development on biotechnology
- Company no.
- 08699350
- Incorporated
- 20/09/2013
- Employees
- 5
ADDIBLE LTD
ActiveSpitfire House 19 Falcon Court, Preston Farm Industrial Estate, Stockton-On-Tees TS18 3TU
- Activity
- Other research and experimental development on natural sciences and engineering
- Company no.
- 12633636
- Incorporated
- 30/05/2020
- Employees
- 7
AMPERSAND HEALTH LIMITED
Active76 Portland Place, London W1B 1NT
- Activity
- Other research and experimental development on natural sciences and engineering
- Company no.
- 11584266
- Incorporated
- 24/09/2018
- Employees
- 5
About OXFORD DRUG DESIGN LIMITED
A short description of the company, written from its Companies House record.
OXFORD DRUG DESIGN LIMITED is a private limited company registered in the United Kingdom, based in Oxford Centre For Innovation Blue Boar Court, 9 Alfred Street, Oxford OX1 4EH. Companies House classifies its business as Research and experimental development on biotechnology. It has been on the register for 24 years 11 months.
The register currently records it as active. Its 2025 accounts report net assets of £438.86K and 7 employees.
OXFORD DRUG DESIGN LIMITED: frequently asked questions
Answered from this company's own registry record and filed figures.
What does OXFORD DRUG DESIGN LIMITED do?
Companies House records OXFORD DRUG DESIGN LIMITED under one registered business activity: Research and experimental development on biotechnology (72.11 - SIC 2007).
Is OXFORD DRUG DESIGN LIMITED still active?
OXFORD DRUG DESIGN LIMITED is recorded as active on the Companies House register, and has been on it since 17/10/2001.
What are OXFORD DRUG DESIGN LIMITED's latest reported financials?
The most recent accounts Okredo holds cover 2025 and report net assets of £438.86K, total assets of £565.15K, cash in bank of £432.12K and total liabilities of £126.29K.
When did OXFORD DRUG DESIGN LIMITED last file with Companies House?
The most recent document on the record is dated 04/09/2026: Statement of capital following an allotment of shares on 2026-07-17, less than a month ago.
When are OXFORD DRUG DESIGN LIMITED's next filings due?
On the current registry record, accounts are due by 30/09/2026.
Who runs OXFORD DRUG DESIGN LIMITED?
Companies House lists 27 officers (6 currently in post) and 2 people with significant control (1 current).